 | We want to help you or your loved one throughout treatment with TAFINLAR + MEKINIST. Here, you will find educational resources and information about financial aid and our Patient Assistance Now Oncology program (PANO, for short). |
Download our Caregiver’s Brochure
Novartis Oncology Universal Co-pay Program
You may be eligible for immediate co-pay savings on your next prescription of TAFINLAR or MEKINIST.
Eligible patients with private insurance may pay $0 per month* ($0 per month for a 30-day supply of TAFINLAR and $0 for a 30-day supply of MEKINIST). Co-pay of $0 is only for TAFINLAR and MEKINIST combination therapy
Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*
*Limitations apply. This offer is only available to patients with private insurance. The program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice. For full Terms and Conditions, visit CoPay.NovartisOncology.com or call 1-877-577-7756.
To find out if you are eligible for the Universal Co-pay Program, call 1-877-577-7756 or visit CoPay.NovartisOncology.com.
Patient Assistance Now Oncology
Our Patient Assistance Now Oncology (PANO) program was created to assist you with accessing your Novartis medicine(s)—from insurance verification to financial assistance—all through a knowledgeable and supportive call center.
Free Trial and Access Program
With the Free Trial and Access Program, you can receive a free supply of TAFINLAR + MEKINIST for a US Food and Drug Administration–approved indication. The supply can be shipped directly to your home or another convenient location so your child can start treatment immediately. Program rules may vary by product.
Ask your health care professional to help you apply for the PANO Free Trial and Access Program.
To learn more, call 1-800-282-7630 or visit Patient.NovartisOncology.com.
